High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from framingham to the veterans affairs high-density lipoprotein intervention trial
Top Cited Papers
- 1 December 2000
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 86 (12) , 19-22
- https://doi.org/10.1016/s0002-9149(00)01464-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- High Density Lipoprotein and Coronary Heart Disease: Lessons From Recent Intervention TrialsPreventive Cardiology, 2000
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterolThe American Journal of Cardiology, 1996
- Distribution of lipids in 8,500 men with coronary artery diseaseThe American Journal of Cardiology, 1995
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989
- Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart StudyJAMA, 1988
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977